Advertisement

Topics

Horizon Pharma Announces Health Canada Approval Of PROCYSBI (Cysteamine Delayed-Release Capsules) For The Treatment Of Nephropathic Cystinosis

20:00 EDT 18 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Horizon Pharma Announces Health Canada Approval Of PROCYSBI (Cysteamine Delayed-Release Capsules) For The Treatment Of Nephropathic Cystinosis

NEXT ARTICLE

More From BioPortfolio on "Horizon Pharma Announces Health Canada Approval Of PROCYSBI (Cysteamine Delayed-Release Capsules) For The Treatment Of Nephropathic Cystinosis"

Advertisement
Quick Search
Advertisement
Advertisement